Acute monocytic leukaemia originating from MLL-MLLT3-positive pre-B cells

British Journal of Haematology

Volumn 150, Issue 5, 2010, Pages 621-623

  Hutter, Caroline ^a   Attarbaschi, Andishe ^a   Fischer, Susanna ^b   Meyer, Claus ^c   Dworzak, Michael ^a,b   König, Margit ^b   Marschalek, Rolf ^c   Mann, Georg ^a   Haas, Oskar A ^a   Panzer Grümayer, E Renate ^a,b  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

^b CHILDREN'S CANCER RESEARCH INSTITUTE   (Austria)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

cellular reprogramming; infant leukaemia; t(9; 11) translocation

Indexed keywords

CD15 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; MIXED LINEAGE LEUKEMIA PROTEIN; MLL MLLT3 PROTEIN; MYELOPEROXIDASE; ONCOPROTEIN; UNCLASSIFIED DRUG; MLL-MLLT3 FUSION PROTEIN, HUMAN;

ACUTE BIPHENOTYPIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; BONE MARROW BIOPSY; CANCER RELAPSE; CHROMOSOME 11Q; CLONAL VARIATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC HETEROGENEITY; HUMAN; IMMUNOPHENOTYPING; LETTER; LEUKEMIA CELL; LUNG LAVAGE; LYMPHOCYTE DIFFERENTIATION; NUCLEOTIDE SEQUENCE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; CANCER STEM CELL; CASE REPORT; FATALITY; FEMALE; GENETICS; INFANT; PATHOLOGY;

FATAL OUTCOME; FEMALE; GENE REARRANGEMENT; HUMANS; INFANT; LEUKEMIA, MONOCYTIC, ACUTE; NEOPLASTIC STEM CELLS; ONCOGENE PROTEINS, FUSION; PRECURSOR CELLS, B-LYMPHOID;

EID: 77955808083     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08239.x     Document Type: Letter

References (10)

1. Armstrong, S.A., Staunton, J.E., Silverman, L.B., Pieters, R., den Boer, M.L., Minden, M.D., Sallan, S.E., Lander, E.S., Golub, T.R. Korsmeyer, S.J. (2002) MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genetics, 30, 41 47.
2. Attarbaschi, A., Mann, G., König, M., Steiner, M., Strehl, S., Schreiberhuber, A., Schneider, B., Meyer, C., Marschalek, R., Borkhardt, A., Pickl, W.F., Lion, T., Gadner, H., Haas, O.A. Dworzak, M.N. (2006) Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity. Clinical Cancer Research, 12, 2988 2994.
3. Bierings, M., Szczepanski, T., van Wering, E.R., Willemse, M.J., Langerak, A.W., Revesz, T. van Dongen, J.J. (2001) Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia. British Journal Haematology, 113, 757 762.
4. Castor, A., Nilsson, L., Astrand-Grundstrom, I., Buitenhuis, M., Ramirez, C., Anderson, K., Strombeck, B., Garwicz, S., Bekassy, A.N., Schmiegelow, K., Lausen, B., Hokland, P., Lehmann, S., Juliusson, G., Johansson, B. Jacobsen, S.E. (2005) Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nature Medicine, 11, 630 637.
5. Chen, W., Kumar, A.R., Hudson, W.A., Li, Q., Wu, B., Staggs, R.A., Lund, E.A., Sam, T.N. Kersey, J.H. (2008) Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer Cell, 13, 432 440.
6. Hotfilder, M., Röttgers, S., Rosemann, A., Schrauder, A., Schrappe, M., Pieters, R., Jürgens, H., Harbott, J. Vormoor, J. (2005) Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34 + CD19- cells. Cancer Research, 65, 1442 1449.
7. Jansen, M.W., Corral, L., van der Velden, V.H., Panzer-Grumayer, R., Schrappe, M., Schrauder, A., Marschalek, R., Meyer, C., den Boer, M.L., Hop, W.J., Valsecchi, M.G., Basso, G., Biondi, A., Pieters, R. van Dongen, J.J. (2007) Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement. Leukemia, 21, 633 641.
8. Krivtsov, A.V., Feng, Z. Armstrong, S.A. (2009) Transformation from committed progenitor to leukemia stem cells. Annals of the New York Academy of Sciences, 1176, 144 149.
9. Pieters, R., Schrappe, M., De Lorenzo, P., Hann, I., De Rossi, G., Felice, M., Hovi, L., LeBlanc, T., Szczepanski, T., Ferster, A., Janka, G., Rubnitz, J., Silverman, L., Stary, J., Campbell, M., Li, C.K., Mann, G., Suppiah, R., Biondi, A., Vora, A. Valsecchi, M.G. (2007) A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet, 370, 240 250.
10. le Viseur, C., Hotfilder, M., Bomken, S., Wilson, K., Röttgers, S., Schrauder, A., Rosemann, A., Irving, J., Stam, R.W., Shultz, L.D., Harbott, J., Jürgens, H., Schrappe, M., Pieters, R. Vormoor, J. (2008) In childhood acute lymphoblastic leukemia, blasts at different stages of immunophenotypic maturation have stem cell properties. Cancer Cell, 14, 47 58.